Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinicians. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Zur HH. Papillomaviruses in the causation of human cancers—a brief historical account. Virology. 2009;384(2):260–5. https://doi.org/10.1016/j.virol.2008.11.046.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinicians. 2018;68(6):394–424.
LaVigne AW, Triedman SA, Randall TC, Trimble EL, Viswanathan AN. Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery. Gynecologic oncology reports. 2017;1(22):16–20. https://doi.org/10.1016/j.gore.2017.08.004.
Zoldoš V, Novokmet M, Bečeheli I, Lauc G. Genomics and epigenomics of the human glycome. Glycoconj J. 2013;30:41–50. https://doi.org/10.1007/s10719-012-9397-y.
Article CAS PubMed Google Scholar
Tian H, Yu JL, Chu X, Guan Q, Liu J, Liu Y. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression. Front Oncol. 2024. https://doi.org/10.3389/fonc.2024.1389713.
Article PubMed PubMed Central Google Scholar
Vajaria BN, Patel PS. Glycosylation: a hallmark of cancer? Glycoconj J. 2017;34:147–56. https://doi.org/10.1007/s10719-016-9755-2.
Article CAS PubMed Google Scholar
Costa AF, Campos D, Reis CA, Gomes C. Targeting glycosylation: a new road for cancer drug discovery. Trends in cancer. 2020;6(9):757–66. https://doi.org/10.1016/j.trecan.2020.04.002.
Article CAS PubMed Google Scholar
Xu Z, Zhang Y, Ocansey DK, Wang B, Mao F. Glycosylation in cervical cancer: new insights and clinical implications. Front Oncol. 2021;16(11): 706862. https://doi.org/10.3389/fonc.2021.706862.
Thobias AR, Patel KA, Gokani R, Parekh C, Desai A, Patel JB, Patel PS. Prevalence of human papilloma virus infection in cervical cancer patients from Western region of India. Indian J Gynecol Oncol. 2019;17:1–6. https://doi.org/10.3390/diagnostics13172765.
Qi F, Isaji T, Duan C, Yang J, Wang Y, Fukuda T, Gu J. ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the α2, 3-sialylation of target proteins. FASEB J. 2020;34(1):881–97. https://doi.org/10.1096/fj.201901793R.
Article CAS PubMed Google Scholar
Cui HX, Wang H, Wang Y, Song J, Tian HU, Xia C, Shen Y. ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules. Oncol Rep. 2016;36(6):3317–24. https://doi.org/10.3892/or.2016.5180.
Article CAS PubMed Google Scholar
Gretschel S, Haensch W, Schlag PM, Kemmner W. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology. 2003;65(2):139–45. https://doi.org/10.1159/000072339.
Article CAS PubMed Google Scholar
Chen SY, Sinha P, Last A, Ettyreddy A, Kallogjeri D, Pipkorn P, Rich JT, Zevallos JP, Paniello R, Puram SV, Van Abel K. Outcomes of patients with single-node metastasis of human papillomavirus-related oropharyngeal cancer treated with transoral surgery. JAMA Otolaryngol-Head & Neck Surgery. 2021;147(1):16–22. https://doi.org/10.1001/jamaoto.2020.3870.
Wei A, Fan B, Zhao Y, Zhang H, Wang L, Yu X, Yuan Q, Yang D, Wang S. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway. Oncotarget. 2016;7(40):65374. https://doi.org/10.18632/oncotarget.11699.
Article PubMed PubMed Central Google Scholar
Rao TC, Beggs RR, Ankenbauer KE, Hwang J, Ma VP, Salaita K, Bellis SL, Mattheyses AL. ST6Gal-I–mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion. J Biol Chem. 2022. https://doi.org/10.1016/j.jbc.2022.101726.
Article PubMed PubMed Central Google Scholar
Zhang X, Pan C, Zhou L, Cai Z, Zhao S, Yu D. Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells. BMC Cancer. 2016;16:1–2. https://doi.org/10.1186/s12885-016-2981-y.
Fobian SF, Mei X, Crezee J, Snoek BC, Steenbergen RD, Hu J, Ten Hagen TL, Vermeulen L, Stalpers LJ, Oei AL. Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review. J Med Virol. 2024;96(6): e29741. https://doi.org/10.1002/jmv.29741.
Article CAS PubMed Google Scholar
Wang X, Huang X, Zhang Y. Involvement of human papillomaviruses in cervical cancer. Front Microbiol. 2018;28(9):2896. https://doi.org/10.3389/fmicb.2018.02896.
Gao HF, Wang QY, Zhang K, Chen LY, Cheng CS, Chen H, Meng ZQ, Zhou SM, Chen Z. Overexpressed N-fucosylation on the cell surface driven by FUT3, 5, and 6 promotes cell motilities in metastatic pancreatic cancer cell lines. Biochem Biophys Res Commun. 2019;511(2):482–9. https://doi.org/10.1016/j.bbrc.2019.02.092.
Article CAS PubMed Google Scholar
Sadeghzadeh Z, Khosravi A, Jazi MS, Asadi J. Upregulation of Fucosyltransferase 3, 8 and protein O-Fucosyltransferase 1, 2 genes in esophageal cancer stem-like cells (CSLCs). Glycoconj J. 2020;37:319–27. https://doi.org/10.1007/s10719-020-09917-z.
留言 (0)